SEC Form D · filed August 17, 2018
GT Biopharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (9)
Steven Weldon · Las Vegas, NVExec · DirectorGeoffrey B. Davis · Washington, Washington, D.C.DirectorKathleen J. Clarence-Smith · Washington, Washington, D.C.DirectorSteven Weldon · Washington, Washington, D.C.Exec · DirectorAnthony J. Cataldo · Washington, Washington, D.C.DirectorJon B. Bonfiglio · TAMPA, FLDirectorRaymond B. Urbanski · TAMPA, FLExecPeter B. Kiener · TAMPA, FLDirectorGeoffrey B. Davis · Washington, Washington, D.C.Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗